These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
606 related articles for article (PubMed ID: 26456962)
1. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis. Yaman B; Nart D; Ekren PK; Çok G; Veral A Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962 [TBL] [Abstract][Full Text] [Related]
2. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung. Argon A; Nart D; Veral A Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390 [TBL] [Abstract][Full Text] [Related]
3. High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lung. Choy B; Findeis-Hosey JJ; Li F; McMahon LA; Yang Q; Xu H Int J Clin Exp Pathol; 2013; 6(11):2542-7. PubMed ID: 24228118 [TBL] [Abstract][Full Text] [Related]
4. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis. Kadota K; Nitadori J; Rekhtman N; Jones DR; Adusumilli PS; Travis WD Am J Surg Pathol; 2015 Sep; 39(9):1170-80. PubMed ID: 25871623 [TBL] [Abstract][Full Text] [Related]
5. Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens. Pelosi G; Rossi G; Bianchi F; Maisonneuve P; Galetta D; Sonzogni A; Veronesi G; Spaggiari L; Papotti M; Barbareschi M; Graziano P; Decensi A; Cavazza A; Viale G J Thorac Oncol; 2011 Jun; 6(6):1039-49. PubMed ID: 21512408 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951 [TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer. Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732 [TBL] [Abstract][Full Text] [Related]
8. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases. Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515 [TBL] [Abstract][Full Text] [Related]
9. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique. Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549 [TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer. Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820 [TBL] [Abstract][Full Text] [Related]
11. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer. Liu K; Chen HL; Gu MM; You QS Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885 [TBL] [Abstract][Full Text] [Related]
12. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Mukhopadhyay S; Katzenstein AL Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. Rekhtman N; Ang DC; Sima CS; Travis WD; Moreira AL Mod Pathol; 2011 Oct; 24(10):1348-59. PubMed ID: 21623384 [TBL] [Abstract][Full Text] [Related]
14. Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer. Sepesi B; Cuentas EP; Canales JR; Behrens C; Correa AM; Vaporciyan A; Weissferdt A; Kalhor N; Moran C; Swisher S; Wistuba I Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):408-415. PubMed ID: 29195578 [TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Pelosi G; Fraggetta F; Pasini F; Maisonneuve P; Sonzogni A; Iannucci A; Terzi A; Bresaola E; Valduga F; Lupo C; Viale G Am J Surg Pathol; 2001 Mar; 25(3):363-72. PubMed ID: 11224607 [TBL] [Abstract][Full Text] [Related]
17. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma. Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544 [TBL] [Abstract][Full Text] [Related]
18. P63 expression in lung carcinoma: a tissue microarray study of 408 cases. Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738 [TBL] [Abstract][Full Text] [Related]
19. Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer. Misch D; Blum T; Boch C; Weiss T; Crolow C; Griff S; Mairinger T; Bauer TT; Kollmeier J Diagn Pathol; 2015 Apr; 10():21. PubMed ID: 25889870 [TBL] [Abstract][Full Text] [Related]
20. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]